Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Pain, Postoperative 1

Interventions

Saline Solution 7Dexmedetomidine 5Bupivacaine 5Acetaminophen 5Ropivacaine 4Lidocaine 4Morphine 3Ketamine 3Control Groups 3Sodium Chloride 2Magnesium Sulfate 2Anesthesia, Spinal 2salicylhydroxamic acid 1oxycodone-acetaminophen 1Transcutaneous Electric Nerve Stimulation 1Surgical Instruments 1Respiration 1Population Groups 1Oxycodone 1Ocoxin 1Nalbuphine 1Meloxicam 1Mastectomy, Segmental 1Ketorolac Tromethamine 1Ketorolac 1Injections, Epidural 1Hydromorphone 1Hemorrhoidectomy 1Drainage 1Dental Occlusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Meloxicam × 1 year × Clear all
NCT07200544 2025-12-15

Meloxicam in Mohs Micrographic Surgery

University of Oklahoma

Phase 4 Recruiting
300 enrolled
Dermatologic

Pain, Postoperative, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡